Vor Biopharma VOR Common stock issuance for private placement
Common stock issuance for private placement at other companies
Other financials
Where this comes from
Reported directly by Vor Biopharma in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfPrivatePlacement.
The official record: Vor Biopharma’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vor Biopharma's common stock issuance for private placement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vor Biopharma's common stock issuance for private placement?
- Vor Biopharma (VOR) reported common stock issuance for private placement of $75M in Q1 2026.
- What does common stock issuance for private placement mean?
- This represents the cash inflows generated from the sale of equity securities directly to private investors. It serves as a key indicator of the company's ability to raise capital outside of public markets to fund research and development.